Reviews Write New Review
[email protected]
Dr. David Hung, MD, founder, President and CEO of Medivation, a biopharmaceutical company focused on the rapid development of therapies to treat cancer and neurodegenerative diseases, was also named the Ernst and Young Entrepreneur Of The Year 2014 National Overall Award winner.
Hung is known for his inspiring work creating Medivation, which identifies, in-licenses and develops visionary technology for life-threatening diseases, as well as the urgency with which he's tackling these illnesses. Medivation acquires early-development stage pharmaceuticals and medical devices that have promising clinical, intellectual property and commercial prospects, and then identifies and executes the strategic pathway that will allow the most rapid, efficient and effective development of these products.
A graduate of Harvard University and the University of California, San Francisco Medical School, Hung is a hematologist, oncologist and scientist. His early work with patients had a profound effect on him, and this experience made him understand that while he was passionate about treating patients as a doctor, he was limited in the number that he could reach. He felt compelled to help more. Hung realized he could affect millions of people by developing new, revolutionary technology, and with that goal in mind, he made the tough decision to leave academic medicine for industry.
His gamble was a success. He founded Medivation in 2003 with a $1 million bridge loan and took the company public through a reverse merger in 2004. Today the company is one of the biotech industry's greatest success stories. Additionally, Hung has richly rewarded those that invested in Medivation at its origin from its original capital raise in 2003, the share price has seen a 100 fold return for those investors.
Related Speakers View all
Francis deSouza
President & CEO of Illumina; Leader in Genomic Seque...
|
|
Mary Jo Gorman
Serial Healthcare Entrepreneur; Licensed Physician; ...
|
|
Francois Nader
President and CEO of NPS Pharmaceuticals
|
|
Christopher Austin
CEO-Partner, Flagship Pioneering & CEO, Vesalius The...
|
|
Giovanni Colella
Co-Founder & CEO at Castlight Health
|
|
Darrell Kirch
President & CEO of the Association of American Medic...
|
|
David Moinina Sengeh
Minister Of Basic and Senior Secondary Education & C...
|
|
Maria Flynn
President & CEO / Orbis Biosciences
|
|
Helena B. Foulkes
Former CEO of Hudson’s Bay and Former President of C...
|
|
Jack Choi
CEO of Anatomage, a company specializing on 3D medic...
|
|
Bill Anderson
CEO of Bayer AG
|
|
Tarek Rabah
President and Chief Executive Officer of Otsuka Nort...
|
|
Dale Whelehan
Visionary Founder & CEO of 4-Day Week Global
|
|
Dr. Robert Huizinga
CEO of Reformation Consulting Services & Author of "...
|
|
Jeffrey Bland
Founder & President of Big Bold Health
|
|
Will McLean
Co-founder & VP of Biology & Regenerative Medicine a...
|
|
Rachel Haurwitz
President & CEO of Caribou Biosciences, Inc.
|
|
Cindy Eckert
Founder & CEO of The Pink Ceiling and Sprout Pharmac...
|
|
Carl Schoellhammer
Quinquennial Postdoctoral Fellow, MIT and Entreprene...
|
|
Jeff Huber
Co-Founder at Triatomic Capital; Founding CEO of GRA...
|